explain 4

profileteju23
Week7-11.22.01DrugstotreatCardiacConditions2.pptx

Medications to treat Heart Failure, Angina & Hypertension

Pharmacology

NSG 220

Dr. Lopez

1

Heart Failure AKA “congestive heart failure”

Progressive/chronic- cardiac output is decreased leading to decline in perfusion to the body and organs.

Heart can’t pump blood throughout the body to meet the body’s need for blood and oxygen

Causes: narrowed arteries (coronary heart disease), high blood pressure, birth defect (congenital heart disease), cardiomyopathy

S/S: shortness of breath, fatigue, edema(peripheral, abdomen) , tachycardia (depends on the side of heart failure), palpitations, dry hacking cough

Treatment Goal:

Improve quality of life and the ability to perform daily activities

Reduce symptoms

Permanent damage to the heart. Looses its tone- too stiff (fibrous/stiff) or too stretched(loss of elasticity)

2

Heart Failure Drugs

Diuretics*- 1st line drug for all patients with s/s of volume overload or hx of volume overload.

RAAS inhibitors

Angiotensin-converting enzyme inhibitors

Angiotensin II receptor blockers

Aldosterone antagonists

Direct renin inhibitors

Beta blockers

Digoxin

Angiotensin II Receptor Blockers

Action

With careful control of dosage, can improve patient’s status

Protect from excessive sympathetic stimulation

Protect against dysrhythmias

Adverse effects

Fluid retention or worsening of HF

Fatigue

Hypotension*

Bradycardia or heart block

Renin-angiotensin-aldosterone system  ( RAAS) inhibitors are a group of drugs that act by inhibiting the  renin-angiotensin-aldosterone system

 ( RAAS) the system that regulates the blood pressure.

3

Medications to treat Heart Failure

Class: Cardiac (Digitalis) Glycosides

Medication: Digoxin [Lanoxin, Lanoxicaps, Digitek]

Used to Treat: Congestive Heart Failure

MOA:

Slows down the heart rate

Increases myocardial contractility

Increased cardiac output

Increases force of ventricular contraction

Hemodynamic benefits

Increased cardiac output

Decreased sympathetic tone

Increased urine production

Decreased renin release

**It does not affect the blood pressure**

Adverse effects

Cardiac dysrhythmias, fatigue, anorexia, bradycardia, hypokalemia

Nursing Implications

Check heart rate (HR) & regularity for 1 full minute before administering

Hold for HR less than 60

Monitor digitalis & potassium levels to avoid toxicity

****Teach patients not to double up if they miss a dose.

***Narrow therapeutic range

Decreased sympathetic tone- reduces blood pressure, lowering heart rate, reduce CO, and stroke volume (via slowing down contractility, decreasing cardiact output, relaxing arteriols and reducing SVR (systemic vascular resistance)

Increased urine production- decreasing fluid volume- lowering water and NA, reducing volume, reducing the blood pressure

Decreased renin release- low renin reduces blood pressure (hypertension).

Peripheral vascular resistance (systemic vascular resistance, SVR) is the resistance in the circulatory system that is used to create blood pressure, the flow of blood and is also a component of cardiac function. When blood vessels constrict (vasoconstriction) this leads to an increase in SVR.

4

Angina

Sudden pain beneath the sternum, that radiates to the left arm, shoulder and jaw.

Cause: blockage “atherosclerosis” of the coronary arteries reducing blood flow to the heart.

Drug therapy goal:

Prevent myocardial infarction

Prevent ischemia and anginal pain

Pharmacological Therapy

Organic Nitrate

Beta Blockers

Calcium Channel blockers

Drug therapy goal medications: cholesterol lowering (reduce plaque) & antiplatelet drugs to prevent (clots)

5

Organic Nitrates

Medication: Nitroglycerin (IV, SL, Translingual spray, PO, Patches, topical ointment)

MOA: dilates the arteries and blood vessels to improve

Therapeutic Action*: Pain relief: Relieves pain by causing vasodilation.

Therapeutic Uses:

Acute Angina: sublingual tabs or translingual spray

Sustained Angina-transdermal patches, topical ointment and sustained-release oral capsules.

Nursing Implications:

*Onset: 2 min (SL); 3 min (PO); 30 min (topical)- can persist up to 1 hour.

Check blood pressure and pulse before each administration 

Blood pressure can drop precipitously after a single dose. 

Hold dose if systolic BP < 90 mm Hg or more than 30 mm Hg below baseline.

Do not discontinue NTG intravenous infusion abruptly–it may result in precipitous rebound hypertension, angina, or coronary artery vasospasms.

A/E:

*Hypotension, headache, reflexive tachycardia, flushing

Reflexive Tachycardia- If blood pressure decreases, the heart beats faster in an attempt to raise it. This is called reflex tachycardia. This can happen in response to a decrease in blood volume (through dehydration or bleeding), or an unexpected change in blood flow.

6

Nitrates

Medications: Isosorbide Mononitrate (SR, IR)- po only, Isosorbide Dinitrate (IR, SR)- PO & SL

MOA: Dilates (widens) blood vessels, making it easier for blood to flow through them and easier for the heart to pump.

Therapeutic Use:

prevent angina attacks (chest pain)

Will not treat an angina attack that has already begun.

Instruct the patient to:

Take this medicine by mouth with a glass of water.

Follow the directions on the prescription label. 

Take this medicine on an empty stomach, at least 30 minutes before or 2 hours after food. Do not take with food.

****Long-acting preparations (transdermal patches, topical ointment, sustained-release oral tablets or capsules) should be discontinued slowly. If they are withdrawn abruptly, vasospasm may result"

*sustained-released- Time-release drugs use a special technology to release small amounts of the medication into a person's system over a long period of time. This is also referred to as sustained release, extended release, or controlled release. These tend to come in pill form and are simply made to be more potent but dissolve slowly

7

Beta Blockers

Medications: Propranolol, metoprolol (PO, IV)

MOA: Blocks stimulation of beta and bet 2 adrenergic receptor sites, reducing certain

Therapeutic Uses: HTN, HF, MI, Stable and Unstable Angina

*Therapeutic effects on pain: Prevent pain of stable angina primarily by decreasing heart rate and contractility, which reduces cardiac oxygen demand.

Adverse Effects: Bradycardia, orthostatic hypotension, impotence

Nursing Implications:

Take with food to increase absorption

Obtain baseline vital signs

Do not discontinue abruptly

8

Calcium Channel Blockers

MOA: Prevents calcium from entering the smooth muscle cells of the heart and arteries.

When calcium enters these cells, it causes a stronger and harder contraction, so by decreasing the calcium, the hearts' contraction is not as forceful. Calcium channel blockers relax and dilate narrowed blood vessels, reduces heart rate and lowers blood pressure

Medications: amlodipine besylate, bepridil, diltiazem, nicardipine

Therapeutic Uses: HTN, variant angina

A/E: Palpitations, Headache, Dizziness, fatigue, nervousness, bradycardia, flushing, hypotension*, syncope, peripheral edema

Nursing Implications

Check blood pressure, heart rate, and cardiac monitor prior to administering diltiazem.

Assess baseline renal (BUN, Cr) and liver function (AST, ALT) lab tests.

Monitor for signs of heart failure (e.g., pulmonary edema, weakness, dyspnea).

Provide analgesic for headache.

Use caution during position changes to prevent orthostatic hypotension.

*hypotension- sign of toxicity

Calcium causes the heart and arteries to contract more strongly. By blocking calcium, calcium channel blockers allow blood vessels to relax and open.

Decrease systemic vascular resistance- decrease afterload.

Syncope is a temporary loss of consciousness usually related to insufficient blood flow to the brain “fainting or passing out”

9

Hypertension

Primary “Essential”

No identifiable cause

Chronic and progressive

Lifelong condition (treated but not cured)

Secondary

Less than 10% have

There is an identifiable cause

Can be cured (removing the cause or managed by drugs used for primary HTN

Blood pressure Facts

BP categories

Normal

Systolic BP below 120 mm Hg and diastolic BP below 80 mm Hg

Prehypertension

Systolic BP of 120 to 139 mm Hg or diastolic BP of 80 to 89 mm Hg

Hypertension

Systolic BP above 140 mm Hg or diastolic BP above 90 mm Hg

Stage 2 hypertension: Systolic BP and diastolic BP in different categories (e.g., 160/92 mm Hg)

Consequences of uncontrolled or untreated

Heart disease

Myocardial infarction (MI)

Heart failure

Angina pectoris

Kidney disease

Stroke

Medications to treat HTN (cont.)

Diuretics

MOA: Help the body get rid of excess sodium (salt) and water and help control blood pressure. They are often used in combination with additional prescription therapies.

Medications:

Thiazide- Chlorthalidone, chlorothiazide, hydrochlorothiazide, indapamide.

Potassium-sparing- amiloride hydrochloride, spironolactone, triamterene

Loop diuretics- furosemide, bumetanide

Direct Acting vasodilators

Cause the muscle in the walls of the blood vessels (mainly arterioles) to relax, allowing the vessel to dilate ultimately allowing improvement in blood flow.

Medications:

Hydralazine

Headaches, heart palpitations, body aches and joint pain (temporary symptoms)

Minoxidil – side effect- hair growth, fluid retention

Medications to treat HTN

Beta-blockers -End in “olol”

Medication: Carvedilol, Labetalol, metoprolol tartrate, atenolol, propranolol hydrochloride

MOA: (lower blood pressure/and HR)

reduce the heart rate, the heart's workload and the heart's output of blood ultimately lowering blood pressure.

A/E:

Bradycardia

AV heart block,

Asthma*

Postural hypotension

Usually only hold these medications for low blood pressure

ACE inhibitors- “pril”

Medications: captopril, lisinopril, fosinopril sodium, enalapril maleate

MOA: Lower BP by preventing the formation of angiotensin II and thereby preventing angiotensin II–mediated vasoconstriction and aldosterone-mediated volume expansion. (Stop angiotensin I from converting to angiotensin II allowing the blood vessels to relax)

**Less effective in African Americans (often see angioedema). Usually not 1st of choice prescribed

*A/E:

Persistent dry, hacking cough* (3.9% and 35% among patients )

First-dose hypotension

Angioedema*

hyperkalemia

Angiotensin is a chemical that causes the arteries to become narrow, especially in the kidneys but also throughout the body. ACE stands for Angiotensin-converting enzyme. ACE inhibitors help the body produce less angiotensin, which helps the blood vessels relax and open up, which, in turn, lowers blood pressure.

*Non-selective beta-blockers cause asthma symptoms in people with asthma. They cause the airways to narrow and become more sensitive.

(first dose to months later) The mechanism of ACE-I-induced cough is still unclear. The possible mediators that play a role in the development of cough are bradykinin and substance P, which are destroyed by ACE. Thus, bradykinin and substance P accumulate in the upper and lower respiratory tracts by inhibition of this enzyme by ACE-I.

Dry cough- avoid in patients with sleep apnea

13

ARBS (angiotensin II receptor blockers) end in “tan”

Medications: Losartan, Valsartan, Irbesartan

MOA: Inhibits angiotensin converting enzyme from producing angiotensin 2 (the major vasoconstrictor), which narrows the blood vessels causing your heart to work harder. They block angiotensin II from binding to the receptors on the blood vessels. It also triggers the release of aldosterone.

Used treat:

Lowers blood pressure

Heart failure

Diabetic Nephropathy- (DM II)- slow down progression of the disease, decrease blood pressure, decrease proteinuria

Nursing:

Assess the blood pressure and heart rate

Monitor potassium levels

Monitor kidney function (labs)- BUN (5-20), Creatinine (0.6-1.2 mg) & urine output (30 cc/hr).

Teach patients: Monitor blood (hypotension), avoid salt substitutes with Potassium, avoid potassium sparing (Arbs can increase medication), never stop the medication on their own. Do not take a missed dose.

RAAS- (system manages the blood pressure)- increases blood pressure when needed. Increase blood volume.

Angio-tension converting enzyme is found in the lungs, heart, arteries, kidneys and intestines.

ACE inhibitors and  ARBs work on the same biochemical pathway in the body to stop high blood pressure, but at different spots.

ACE inhibitors block a natural substance in the body called angiotensin I from being converted to angiotensin II. Angiotensin II constricts the blood vessels, causing blood pressure to increase. Stopping the conversion of angiotensin I to angiotensin II results in blood vessel relaxation and a decrease in blood pressure.

ARBs also target the angiotensin pathway, but they work by blocking angiotensin II from binding to receptors on the blood vessels that affect blood vessel constriction. In the end, this also results in blood vessel relaxation and a decrease in blood pressure.

Kidney disease- high blood pressure, forces more protein into the urine- lowering bp, reduces the proteinuria

14

Treatment for HTN

Lifestyle Modifications

Sodium restriction

DASH (Dietary Approaches to Stop Hypertension) eating plan

Alcohol restriction

Aerobic exercise

Smoking cessation

Weight Loss

Maintenance of potassium and calcium intake (important for cardiac function)

Pharmacologic Therapy

Diuretics

Direct-acting vasodilators: hydralazine and minoxidil

Beta-Adrenergic Blockers

ACE Inhibitors

Calcium Channel blockers

15

16

Questions?

media1.m4a

image1.png

media2.m4a

image2.png

media3.m4a

media4.m4a

media5.m4a

image3.png

media6.m4a

media7.m4a

media8.m4a

media9.m4a

media10.m4a

image4.png

media11.m4a

media12.m4a

media13.m4a

media14.m4a

media15.m4a

image5.png

image6.png

media16.m4a

image7.png